Advertisement
Screener

FENNEC PHARMACEUTICALS INC. (FENC) Cash Flow Breakdown

FENNEC PHARMACEUTICALS INC. Cash Flow Breakdown

Cash flow breakdown shows where FENNEC PHARMACEUTICALS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $12.47M went out.
  • Fiscal year ended 2025-12-31: from financing, $22.63M came in.
  • Fiscal year ended 2025-12-31: change in cash, $10.15M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$12.47M-$21.43M*-$187.00K$2.19M$42.05M*$10.15M
2024-12-31$26.98M-$13.00M-$176.00K$1.30M*$13.37M
2023-12-31-$17.14M$5.00M-$78.00K$1.72M$3.00K-$10.51M
2022-12-31-$18.06M-$5.00M$24.93M-$194.00K$928.00K$238.00K$2.67M
2021-12-31-$14.22M$5.00M$33.00K-$9.24M
2020-12-31-$15.60M$31.97M$16.69M
2019-12-31-$9.06M$0.00-$9.13M
2018-12-31-$7.83M$0.00$210.00K$2.14M*-$5.48M
2017-12-31-$3.64M$0.00$27.38M$594.00K*$24.33M
2016-12-31-$2.12M$0.00$5.00M$2.98M
2015-12-31-$1.86M$0.00$0.00-$1.36M
2014-12-31-$1.70M$0.00$2.18M$644.00K
2013-12-31-$2.21M$0.00$0.00$1.57M$0.00-$640.00K
2012-12-31-$2.99M$0.00$0.00$0.00$0.00-$2.99M
2011-12-31-$3.23M$0.00$0.00$2.57M$0.00-$650.00K
2010-12-31-$1.93M$7.19M$5.26M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$50.00K*-$941.00K*$1.96M*
2026-03-31$2.38M-$311.00K$1.32M$3.39M
2025-12-31-$5.96M*-$26.00K*$205.00K*$20.62M*
2025-09-30$1.49M*-$50.00K*$1.80M*
2025-06-30-$3.69M*-$99.00K*-$185.00K*
2025-03-31-$4.32M-$12.00K$371.00K-$3.96M
2024-12-31-$1.47M*-$9.00K*$797.00K*-$13.00M*
2024-09-30-$2.21M*-$58.00K*-$470.00K*
2024-06-30-$8.39M*-$90.00K*$347.00K*
2024-03-31$39.05M-$19.00K$627.00K-$1.74M*$37.91M
2023-12-31-$4.86M*-$17.00K*$747.00K*$5.00M*
2023-09-30-$2.76M*$215.00K*
2023-06-30-$3.95M*$541.00K*
2023-03-31-$5.58M-$20.00K$213.00K-$5.38M
2022-12-31-$6.80M*$0.00*-$65.00K*-$28.00K*$679.00K*
2022-09-30-$5.01M*$188.00K*$19.66M*
2022-06-30-$3.39M$46.00K*
2022-03-31-$2.86M$15.00K-$2.84M
2021-12-31-$3.25M*$0.00*$9.00K*
2021-09-30-$2.96M$0.00*$0.00*-$2.96M
2021-06-30-$4.43M$5.00M$24.00K$542.00K
2021-03-31-$3.59M-$3.59M
2020-12-31-$3.28M*$0.00*
2020-09-30-$5.45M$0.00-$5.56M
2020-06-30-$3.12M$31.97M$28.83M
2020-03-31-$3.75M-$3.75M
2019-12-31-$1.59M*$0.00*
2019-09-30-$2.23M$0.00-$2.23M
2019-06-30-$2.76M$0.00-$2.76M
2019-03-31-$2.48M-$2.55M
2018-12-31-$2.93M*$184.00K*$1.00M*-$1.74M*
2018-09-30-$1.60M$0.00-$1.12M
2018-06-30-$1.57M$0.00-$1.08M
2018-03-31-$1.73M$26.00K-$1.54M
2017-12-31-$1.32M*$237.00K*$19.66M*$18.57M*
2017-09-30-$958.00K$261.00K-$544.00K
2017-06-30-$688.00K$7.67M*$6.98M
2017-03-31-$675.00K$0.00-$675.00K
2016-12-31-$611.00K*$0.00*-$611.00K*
2016-09-30-$544.00K$0.00-$544.00K
2016-06-30-$470.00K$0.00$5.01M*$4.54M
2016-03-31-$499.00K$0.00$102.00K-$397.00K
2015-12-31-$424.00K*$0.00*-$449.00K*-$424.00K*
2015-09-30-$509.00K$0.00$21.00K-$488.00K
2015-06-30-$511.00K$0.00$449.00K-$62.00K
2015-03-31-$418.00K$0.00$27.00K-$391.00K
2014-12-31-$468.00K*$0.00*$2.02M*$1.71M*
2014-09-30-$443.00K$0.00$0.00$21.00K$0.00-$422.00K
2014-06-30-$410.00K$0.00$0.00$87.00K$0.00-$323.00K
2014-03-31-$378.00K$0.00$0.00$53.00K$0.00-$325.00K
2013-12-31-$445.00K*$0.00*$0.00*$1.57M*$0.00*$1.13M*
2013-09-30-$469.00K$0.00$0.00$0.00$0.00-$469.00K
2013-06-30-$889.00K$0.00$0.00$0.00$0.00-$889.00K
2013-03-31-$407.00K$0.00$0.00$0.00$0.00-$407.00K
2012-12-31-$557.00K*$0.00*$0.00*$0.00*$0.00*-$557.00K*
2012-09-30-$726.00K$0.00$0.00$0.00$0.00-$726.00K
2012-06-30-$1.13M$0.00$0.00$0.00$0.00-$1.13M
2012-03-31-$578.00K$0.00$0.00$0.00$0.00-$578.00K
2011-12-31-$767.00K*$0.00*$0.00*$0.00*$0.00*-$877.00K*
2011-09-30-$636.00K$0.00$0.00$0.00$0.00-$636.00K
2011-06-30$1.77M$0.00$0.00$0.00$0.00$1.79M
2011-03-31-$1.05M$0.00$0.00$0.00$0.00-$924.00K
2010-12-31-$655.00K*-$655.00K*
2010-09-30-$550.00K-$550.00K
2010-06-30-$386.00K$7.19M*$6.80M

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60